BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30520705)

  • 1. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
    Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
    Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
    Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli.
    Martewicz S; Luni C; Serena E; Pavan P; Chen HV; Rampazzo A; Elvassore N
    Ann Biomed Eng; 2019 Mar; 47(3):852-865. PubMed ID: 30569242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
    Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?
    Moccia F; Lodola F; Stadiotti I; Pilato CA; Bellin M; Carugo S; Pompilio G; Sommariva E; Maione AS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic cardiomyopathy.
    Pilichou K; Thiene G; Bauce B; Rigato I; Lazzarini E; Migliore F; Perazzolo Marra M; Rizzo S; Zorzi A; Daliento L; Corrado D; Basso C
    Orphanet J Rare Dis; 2016 Apr; 11():33. PubMed ID: 27038780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of arrhythmogenic cardiomyopathy.
    Austin KM; Trembley MA; Chandler SF; Sanders SP; Saffitz JE; Abrams DJ; Pu WT
    Nat Rev Cardiol; 2019 Sep; 16(9):519-537. PubMed ID: 31028357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
    Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
    Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathobiology of arrhythmogenic cardiomyopathy.
    Saffitz JE
    Annu Rev Pathol; 2011; 6():299-321. PubMed ID: 21073337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
    Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
    Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bezzerides VJ; Zhang D; Pu WT
    Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.